Gene: STK40
Official Full Name: serine/threonine kinase 40provided by HGNC
Gene Summary: Predicted to enable ATP binding activity; protein serine kinase activity; and protein serine/threonine kinase activity. Predicted to be involved in regulation of MAPK cascade. Predicted to act upstream of or within several processes, including glycogen metabolic process; lung development; and respiratory system process. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05133 | STK40 Knockout cell line (HeLa) | Human | STK40 | 1:3~1:6 | Negative | Online Inquiry |
KO05134 | STK40 Knockout cell line (HCT 116) | Human | STK40 | 1:2~1:4 | Negative | Online Inquiry |
KO05135 | STK40 Knockout cell line (HEK293) | Human | STK40 | 1:3~1:6 | Negative | Online Inquiry |
KO05136 | STK40 Knockout cell line (A549) | Human | STK40 | 1:3~1:4 | Negative | Online Inquiry |
STK40 Gene Knockout Cell Lines are genetically engineered cell lines designed to study the function of the STK40 gene by specifically eliminating its expression through a CRISPR-Cas9 based knockout strategy. This innovative tool allows researchers to elucidate the role of STK40 in various biological processes, including signal transduction, cellular growth, and apoptosis, by providing a platform for loss-of-function studies.
The STK40 gene encodes a serine/threonine kinase that is implicated in various cellular signaling pathways, making its knockout an invaluable resource in both fundamental research and drug discovery. By utilizing these specialized cell lines, scientists can investigate the impact of STK40 absence on cellular function and identify downstream target genes and pathways affected by its loss. The precise mechanism of action allows for reproducibility in experiments, empowering researchers to draw more robust conclusions from their studies.
In clinical settings, understanding the role of genes like STK40 is crucial for the development of targeted therapies for disease states where STK40 is dysregulated. The ability to manipulate this gene at a cellular level is particularly advantageous in exploring therapeutic approaches for various cancers and genetic disorders, providing insights that could lead to novel treatment paradigms.
The unique selling point of STK40 Gene Knockout Cell Lines lies in their customization and validation, ensuring that they meet the highest standards of research rigor. They offer a reliable alternative to traditional RNA interference methods, which can often be transient and show off-target effects. Researchers will find significant value in the durability and specificity of our cell lines, which facilitate longer-term studies and more consistent data.
Investing in STK40 Gene Knockout Cell Lines is not just an investment in a research tool; it is a commitment to advancing scientific understanding and the potential development of innovative therapies. Our company is dedicated to providing high-quality, validated biological products, supported by expert knowledge and a commitment to enhancing research outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.